Samsung Biologics (Korea) Analysis
| 207940 Stock | 934,000 2,000 0.21% |
Samsung Biologics Co is fairly valued with Real Value of 934000.0 and Hype Value of 934000.0. The main objective of Samsung Biologics stock analysis is to determine its intrinsic value, which is an estimate of what Samsung Biologics Co is worth, separate from its market price. There are two main types of Samsung Biologics' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Samsung Biologics' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Samsung Biologics' stock to identify patterns and trends that may indicate its future price movements.
The Samsung Biologics stock is traded in Korea on Korea Stock Exchange, with the market opening at 09:00:00 and closing at 15:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Korea. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Samsung Biologics' ongoing operational relationships across important fundamental and technical indicators.
Samsung |
Samsung Stock Analysis Notes
About 75.0% of the company shares are owned by insiders or employees . The company recorded earning per share (EPS) of 2417.83. Samsung Biologics had not issued any dividends in recent years. The entity had 476:471 split on the 28th of February 2022. For more info on Samsung Biologics Co please contact John Rim at (82) 33 455 3825 or go to www.samsungbiologics.com.Samsung Biologics Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Samsung Biologics' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Samsung Biologics Co or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Samsung Biologics generated a negative expected return over the last 90 days | |
| About 75.0% of the company shares are owned by insiders or employees |
Samsung Market Capitalization
The company currently falls under 'Mega-Cap' category with a current market capitalization of 57.3 T. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Samsung Biologics's market, we take the total number of its shares issued and multiply it by Samsung Biologics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Samsung Profitablity
Samsung Biologics' profitability indicators refer to fundamental financial ratios that showcase Samsung Biologics' ability to generate income relative to its revenue or operating costs. If, let's say, Samsung Biologics is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Samsung Biologics' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Samsung Biologics' profitability requires more research than a typical breakdown of Samsung Biologics' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.2 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.32 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.32. Technical Drivers
As of the 23rd of November, Samsung Biologics has the Variance of 1.93, coefficient of variation of (74,870), and Risk Adjusted Performance of 0.0035. Samsung Biologics technical analysis provides you with a way to harness past market data to determine a pattern that measures the direction of the company's future prices.Samsung Biologics Price Movement Analysis
The output start index for this execution was two with a total number of output elements of fifty-nine. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Samsung Biologics middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Samsung Biologics. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Samsung Biologics Outstanding Bonds
Samsung Biologics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Samsung Biologics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Samsung bonds can be classified according to their maturity, which is the date when Samsung Biologics Co has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Samsung Biologics Predictive Daily Indicators
Samsung Biologics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Samsung Biologics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 704.66 | |||
| Daily Balance Of Power | 0.1538 | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 932500.0 | |||
| Day Typical Price | 933000.0 | |||
| Market Facilitation Index | 0.26 | |||
| Price Action Indicator | 2500.0 | |||
| Period Momentum Indicator | 2000.0 | |||
| Relative Strength Index | 66.24 |
Samsung Biologics Forecast Models
Samsung Biologics' time-series forecasting models are one of many Samsung Biologics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Samsung Biologics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Samsung Biologics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Aroon Oscillator Now
Aroon OscillatorAnalyze current equity momentum using Aroon Oscillator and other momentum ratios |
| All Next | Launch Module |
Complementary Tools for Samsung Stock analysis
When running Samsung Biologics' price analysis, check to measure Samsung Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Samsung Biologics is operating at the current time. Most of Samsung Biologics' value examination focuses on studying past and present price action to predict the probability of Samsung Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Samsung Biologics' price. Additionally, you may evaluate how the addition of Samsung Biologics to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |